Objective: The aim of this study was to investigate the efficacy of vascular graft coatings used in the aortic position to prevent vascular graft infection (VGI).

The case of a 72 year old man is reported who presented to the outpatient clinics for treatment of new intermittent claudication (4 weeks). In 2018, the patient underwent elective Endovascular Aneurysm Repair (EVAR) for aa asymptomatic 6.0 cm Abdominal Aortic Aneurysm (AAA). The patient did not comply to postoperative follow-up after year 1 although the aneurysm did not shrink. Clinical findings showed diminished femoral pulses bilaterally. Computed tomography angiography showed disconnection of the 2 components of the EVAR repair (Endoleak Type III). Occlusion of the distal main body caused the claudication. Immediately, the manufacturer was contacted for evaluation regarding Re-EVAR. Open repair appeared too risky as the patient was positive at routine COVID-19 testing. During the wait for a decision on endovascular repair, the patient was found dead in the bathroom. Autopsy confirmed AAA rupture as cause of death.

Objective: We report hereby the case of a 79-year-old female with a symptomatic normal flow / high gradient severe aortic stenosis - mean gradient of 43 mm Hg- and a significant supra-aortic trunk stenosis (left carotid artery: 90–99%; right carotid artery: 50–70%), and who was hospitalized for progressive dyspnea New York Heart Association (NYHA) stage III. In this high-risk patient, it was decided to perform a transaortic valve implantation (TAVI). Because of an history of stenting of both common iliac arteries in a context of an arterial insufficiency of the lower limbs (Leriche classification stage III) and diffuse thoraco-abdominal aorta atheromatosis with thigh stenosis to 4 mm of diameter, an alternative approach to the transfemoral transaortic valve implantation (TF-TAVI) one was needed. It was decided to perform a TC- TAVI with EDWARDS S3 23 mm valve through after a left endarterectomy in the same operating time.

Introduction: Thoracic endovascular aortic repair (TEVAR) was introduced in the early 1990?s, and long-term follow-up studies are warranted in current guidelines.

Objective: Raynaud Phenomenon (RP) is one of the most common diseases of microcirculation. Calcium antagonists, ACE inhibitors and β1-blockers are the most commonly used in therapy of RP. The aim of this study was to estimate a potential usefulness of Sulodexide in the treatment of RP, by evaluation of the drug influence on capillary blood flow and the quality of life in patients with RP.

Background: Thoracic aortic surgery have improved morbidity and mortality. However, women are at increased postoperative risk of adverse outcomes compared with men. The objective was to compare early outcomes in both genders undergoing pre-emptive ascending aortic replacement (AAR).

Objectives: Patients undergoing surgical or endovascular carotid intervention should receive optimal medical therapy, including LLT . Statins reduce the 10-year risk of stroke/death (17.9 vs. 7.6%) after carotid endarterectomy (1). Current guidelines advise high-intensity statin (HIS) treatment and achieve a target LDL-C level of < 1.8mmol/L (2). This study aims to explores trends in titration of lipid lowering therapy and LDL-C levels in patients undergoing carotid intervention prior to, at the time of and 1 year following carotid intervention.

Background: Thoracic aortic surgery have improved morbidity and mortality. However, women are at increased postoperative risk of adverse outcomes compared with men. The objective was to compare early outcomes in both genders undergoing pre-emptive ascending aortic replacement (AAR).

Purpose: We compared the outcomes between the total endovascular approach using a unibody bifurcated aortoiliac endograft and the gold standard aortobifemoral bypass (ABF) surgery for the management of extensive aortoiliac occlusive disease (AIOD).

Introduction: Abdominal aortic aneurysms (AAA) are defined as a progressive weakening of the aortic wall, leading to gradual dilatation. We hypothesize that dysfunction of vascular smooth muscle cells (vSMC), the major cell type within the aortic wall, plays a paramount role in AAA pathophysiology. The aim of this study is to investigate in vitro contractility of human AAA vSMC compared with non-pathologic vSMC.